Get Ready for Liftoff: For All Mankind Season 5 Is Coming
Apple TV+ has delivered several hits, but few have had the long-lasting impact of For All Mankind. This alternate-history sci-fi series has gained a devoted following with its gripping plot, emotional storytelling, and what-if scenarios about the space race. As Season 4 left fans on a high note, many are now asking the burning question: Will there be a season 5 of For All Mankind? Here’s everything we know so far about
What Is For All Mankind All About?
Before diving into the new season, let’s recap what makes this series so compelling.
The series masterfully combines historical events with fictional twists, offering a gripping narrative that blends drama, science fiction, and geopolitical intrigue.
Will There Be a Season 5 of For All Mankind?
The good news is: Yes, there will be a Season 5 of For All Mankind! Apple TV+ officially renewed the series following the success and critical acclaim of Season 4. The announcement has fans buzzing with excitement as the show's universe continues to expand across decades and planets.
The creators, Ronald D. Moore, Matt Wolpert, and Ben Nedivi, have all expressed interest in exploring more of the 21st century and beyond in future seasons. Given the show's time jumps each season, Season 5 is expected to fast-forward another 8–10 years.
For All Mankind Season 5 Release Date: What to Expect
While an exact release date for For All Mankind Season 5 has not been confirmed yet, early predictions point to a late 2025 premiere. Historically, new seasons of the show have followed a 1.5 to 2-year gap between releases. Given that Season 4 premiered in late 2023, Season 5 is likely to follow suit in late 2025 or early 2026.
Filming timelines, post-production needs, and ongoing creative development will also affect the release date, but Apple TV+ has a reputation for quality over speed—so fans can rest assured it’ll be worth the wait.
Returning Cast: Who’s Coming Back for Season 5?
While the cast for Season 5 hasn't been officially confirmed, several key characters are expected to return:
-
Joel Kinnaman as Ed Baldwin – the aging astronaut and central figure of the series.
-
Wrenn Schmidt as Margo Madison – now exiled in Russia, her future arc is a major plot point.
-
Krys Marshall as Danielle Poole – a trailblazer in space exploration.
-
Edi Gathegi as Dev Ayesa – a visionary entrepreneur from Season 4.
Given the show's structure and time jumps, For All Mankind Season 5 may also introduce a new generation of characters as children from earlier seasons take on leadership roles in space missions and politics.
Where Will Season 5 Take Us?
With each new season, For All Mankind jumps ahead in time and ventures deeper into space. Season 4 focused heavily on the Mars colony and the challenges of long-term survival on the red planet. Season 5 may continue exploring Mars or even take us to Jupiter’s moons or Saturn’s orbit, as humanity’s quest for space colonization accelerates.
Key plot questions for Season 5 include:
-
Will Margo return to the U.S. after her exile?
-
How will international tensions evolve with multiple nations on Mars?
-
Will new private space companies rise to challenge NASA?
The alternate history approach keeps fans guessing, which is part of what makes this series so binge-worthy.
Why Fans Can’t Wait for For All Mankind Season 5
The fanbase for
With Season 5 on the horizon, fans are eager to see how the show addresses contemporary themes like climate change, AI, and international cooperation through its futuristic lens.
Where to Watch For All Mankind
All seasons of For All Mankind are available exclusively on Apple TV+, making it one of the platform’s flagship original series. If you haven’t caught up yet, now is the perfect time to binge the first four seasons and prepare for what’s next.
Whether you’re a sci-fi enthusiast or just a fan of great storytelling, For All Mankind Season 5 is shaping up to be a must-watch. Although the exact release date of Season 5 hasn’t been revealed, excitement is building as the show prepares to leap even further into the future. With compelling characters, bold storylines, and big ideas, this series continues to push the boundaries of what television can achieve.
So if you've been wondering, “Will there be a Season 5 of For All Mankind?” — the answer is a resounding yes. And it's going to be out of this world.
Dad with deadly brain cancer that kills in a year is cancer free after taking new drug
A breakthrough drug is fighting brain cancer head-on.
Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year. There is no cure for the highly aggressive disease — many patients survive just nine months after diagnosis.
Ben Trotman was diagnosed with glioblastoma in October 2022 at 40.
Treatment focuses on managing symptoms and extending life via surgery to remove as much of the tumor as possible and radiation therapy and chemotherapy to destroy cancer cells.
Now, researchers from University College London Hospitals are recruiting glioblastoma patients for a trial of the immunotherapy drug ipilimumab. Sold under the brand name Yervoy, the monoclonal antibody stimulates the immune system to recognize and attack cancer cells.
Oncologists are optimistic since a UK father shows no signs of having a tumor after he took ipilimumab before his glioblastoma treatment.
Ben Trotman was diagnosed with glioblastoma in October 2022 at 40.
“The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy,” said Dr. Paul Mulholland, the consultant medical oncologist leading the trial.
“We saw with Ben, the one patient recruited to the immunotherapy study, NeAT-GLIO, that he has had clear scans since having the treatment and the tumor hasn’t returned more than two and a half years later.”
Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year.
Trotman met with Mulholland, who enrolled him in a clinical trial for ipilimumab. He was the first patient in the world — and the only person in the trial — to take the drug before glioblastoma treatment.
“Getting this diagnosis was the most traumatic experience,” said Trotman’s wife, Emily.
“We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live.”
After taking the drug, Ben underwent radiotherapy and chemotherapy.
Two years and eight months later, his scans are clear.
“It is very unusual to have a clear scan with glioblastoma, especially when he didn’t have the follow-up surgery that had been planned to remove all of the tumor that was initially visible on scans,” Mulholland said.
Ben and Emily Trotman wed in 2023, after he began his immunotherapy treatment.
“We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumor at bay,” he added, “and it has so far, which we are delighted to see.”
In January 2023, months after his diagnosis, Ben married Emily. The couple welcomed a daughter, Mabel, earlier this year.
They enjoy taking her for walks along with their rescue dog, Jerry.
“We are trying to live as normal a life as possible,” Emily said.
“We are in a unique position of which there is no precedent and which comes with a great deal of uncertainty,” she continued. “We want to live each day as if it were our last, but we also want to plan for the future, which we hope to have.”
Researchers plan to recruit 16 glioblastoma patients like Ben over 18 months.
After taking ipilimumab, the trial participants will undergo radiotherapy and chemotherapy and perhaps surgery depending on the extent of their disease.
Dr. Paul Mulholland and Dame Siobhain McDonagh, who raised funds for the new clinical trial of ipilimumab.
The trial is being funded by Dame Siobhain McDonagh, a member of the British Parliament, whose sister died of glioblastoma in 2023.
“My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma,” McDonagh said. “Changing this was Margaret’s final campaign and one that I have continued in her memory.”
Treatment will take place at the NIHR UCLH’s Clinical Research Facility at the National Hospital for Neurology and Neurosurgery.
“I am delighted that this new trial, with the same immunotherapy drug I received, is going ahead and others will have the opportunity to take part,” Ben said. “It will give people newly diagnosed with glioblastoma some hope.”
